Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

Define Study Investigators, Raymond Hupperts

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

INIS

Agricultural and Biological Sciences